ID

15117

Beschrijving

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01508949

Link

https://clinicaltrials.gov/show/NCT01508949

Trefwoorden

  1. 16-05-16 16-05-16 -
Geüploaded op

16 mei 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes NCT01508949

Eligibility Diabetes NCT01508949

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01508949
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Beschrijving

diabetes mellitus type 2

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
diet treated and/or subjects in monotherapy with sulphonylurea or repaglinide
Beschrijving

diet therapy; sulphonylurea or repaglinide

Datatype

boolean

Alias
UMLS CUI [1]
C0012159
UMLS CUI [2]
C0038766
UMLS CUI [3]
C0246689
hba1c for diet treated subjects 6.5-12%, both inclusive
Beschrijving

hba1c

Datatype

boolean

Alias
UMLS CUI [1]
C0019018
hba1c for sulphonylurea or repaglinide treated subjects maximum 10%
Beschrijving

hba1c for sulphonylurea or repaglinide treated subjects

Datatype

boolean

Alias
UMLS CUI [1,1]
C0038766
UMLS CUI [1,2]
C0019018
UMLS CUI [2,1]
C0246689
UMLS CUI [2,2]
C0019018
body mass index (bmi) at least 27 kg/m^2
Beschrijving

bmi

Datatype

boolean

Alias
UMLS CUI [1]
C1305855
euthyroid subjects
Beschrijving

euthyroid

Datatype

boolean

Alias
UMLS CUI [1]
C0117002
fasting blood glucose 7-14 mmol/l
Beschrijving

fasting blood glucose

Datatype

boolean

Alias
UMLS CUI [1]
C0428568
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
impaired liver function
Beschrijving

impaired liver function

Datatype

boolean

Alias
UMLS CUI [1]
C0086565
impaired renal function
Beschrijving

impaired renal function

Datatype

boolean

Alias
UMLS CUI [1]
C0151746
cardiac problems
Beschrijving

cardiac problems

Datatype

boolean

Alias
UMLS CUI [1]
C0262402
uncontrolled treated/untreated hypertension
Beschrijving

hypertension

Datatype

boolean

Alias
UMLS CUI [1]
C0020538
recurrent severe hypoglycaemia as judged by the investigator
Beschrijving

hypoglycaemia

Datatype

boolean

Alias
UMLS CUI [1]
C0020615
known or suspected allergy to trial product or related products
Beschrijving

allergy to trial product

Datatype

boolean

Alias
UMLS CUI [1]
C0020517
use of any drug (except for ohas (oral hypoglycaemic agents), which in the investigator's opinion could interfere with the glucose level or body weight. stable doses, for 3 months or greater, of thyroid hormone replacement are allowed
Beschrijving

medication

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0202042
UMLS CUI [1,3]
C0005910

Similar models

Eligibility Diabetes NCT01508949

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01508949
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
diabetes mellitus type 2
Item
type 2 diabetes mellitus
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
diet therapy; sulphonylurea or repaglinide
Item
diet treated and/or subjects in monotherapy with sulphonylurea or repaglinide
boolean
C0012159 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
C0246689 (UMLS CUI [3])
hba1c
Item
hba1c for diet treated subjects 6.5-12%, both inclusive
boolean
C0019018 (UMLS CUI [1])
hba1c for sulphonylurea or repaglinide treated subjects
Item
hba1c for sulphonylurea or repaglinide treated subjects maximum 10%
boolean
C0038766 (UMLS CUI [1,1])
C0019018 (UMLS CUI [1,2])
C0246689 (UMLS CUI [2,1])
C0019018 (UMLS CUI [2,2])
bmi
Item
body mass index (bmi) at least 27 kg/m^2
boolean
C1305855 (UMLS CUI [1])
euthyroid
Item
euthyroid subjects
boolean
C0117002 (UMLS CUI [1])
fasting blood glucose
Item
fasting blood glucose 7-14 mmol/l
boolean
C0428568 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
impaired liver function
Item
impaired liver function
boolean
C0086565 (UMLS CUI [1])
impaired renal function
Item
impaired renal function
boolean
C0151746 (UMLS CUI [1])
cardiac problems
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
hypertension
Item
uncontrolled treated/untreated hypertension
boolean
C0020538 (UMLS CUI [1])
hypoglycaemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0020615 (UMLS CUI [1])
allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1])
medication
Item
use of any drug (except for ohas (oral hypoglycaemic agents), which in the investigator's opinion could interfere with the glucose level or body weight. stable doses, for 3 months or greater, of thyroid hormone replacement are allowed
boolean
C0013227 (UMLS CUI [1,1])
C0202042 (UMLS CUI [1,2])
C0005910 (UMLS CUI [1,3])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial